Company intelligence / Profile preview

Omni Biomed

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

OmniBiomed is a medical technology company specializing in the development of artificial intelligence-driven solutions for medical imaging and diagnostics. The company's platform leverages advanced deep learning algorithms to enhance the accuracy and efficiency of disease detection, particularly in oncology and cardiology. By integrating AI into existing clinical workflows, OmniBiomed aims to provide healthcare professionals with actionable insights that facilitate earlier diagnosis and personalized treatment planning. Their technology is designed to improve patient outcomes by reducing diagnostic errors and optimizing the interpretation of complex medical images.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: DeviceSoftware as a Medical Device
Industry: Medical Imaging

Beyond the preview

Go deeper on Omni Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omni Biomed.

Explore the full profile